Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Aurinia appoints Hepion’s Dr. Robert T. Foster to board

Aurinia Pharmaceuticals (NASDAQ:AUPH) appointed Dr. Robert T. Foster, CEO of Hepion Pharmaceuticals, to its board. “As the doctor who discovered voclosporin, and Aurinia’s founder, [Dr. Foster] has a wealth of...

September 21, 2023

Executive Moves

Enzo Biochem names Kara Cannon as interim CEO

Enzo Biochem (NYSE:ENZ) appointed its chief operating officer, Kara Cannon, to be interim CEO after Hamid Erfanian, former CEO, left the company, effective Sept. 5. Mr. Erfanian led the company through the sale of Enzo...

September 6, 2023

Executive Moves

Sernova names Cynthia Pussinen as CEO

Sernova (TSX:SVA; OTCQB:SEOVF; FSE/XETRA:PSH) appointed Cynthia Pussinen as CEO and a member of the board, succeeding Dr. Philip Toleikis, who will serve as chief technology officer. Ms. Pussinen’s expertise spans...

September 5, 2023

Executive Moves

Zoe Heineman joins Hygieia as VP of BD

Closely-held Hygieia, a provider of digital therapeutics for insulin management, hired Zoe Heineman as VP of business development. Ms. Heineman brings more than 30 years of expertise in strategic leadership, operations...

September 1, 2023

Executive Moves

Veteran investment banker Jed Cohen joins Raymond James

Seasoned investment banker Jed Cohen has joined Raymond James as a managing director of its healthcare investment banking practice. The strategic hire underscores the firm’s continuing commitment to expanding the sector...

July 14, 2023

Executive Moves

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

PharmaJet appointed Nanette Cocero, Ph.D., a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background, to the...

July 12, 2023

Executive Moves

iBio names Dr. Martin Brenner and Felipe Duran as permanent CEO and CFO, respectively

iBio (NYSEA:IBIO) appointed Martin Brenner, DVM, Ph.D., as CEO and Felipe Duran as CFO, effective immediately. Dr. Brenner will also continue to serve as iBio’s CSO, a role he has held since December 2020. The...

June 27, 2023

Executive Moves

Marie Mazur appointed chair of PharmaJet board

PharmaJet named Marie Mazur, PharmD, chairwoman of the board, replacing Ron Lowy, who had chaired the board since 2011. “Marie’s experience and leadership will be of great benefit for our company as we are accelerating...

June 6, 2023

Executive Moves

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Kaouthar Lbiati, M.D., as an independent director. Dr. Lbiati received a post-doctorate in clinical oncology from Gustave Roussy Institute in Paris, which is a...

June 6, 2023

Executive Moves

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

The board of Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF; FSE:4PC) appointed Adrian Mendes as CEO, effective immediately, succeeding Jeremy Sobotta, who has resigned for personal reasons, effective June 15, 2023...

June 5, 2023

Executive Moves

Ondine Biomedical names Simon Sinclair as CMO

Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...

June 1, 2023

Executive Moves

Theralase names Roger DuMoulin-White as president and CEO

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Roger DuMoulin-White as president and CEO, succeeding Arkady Mandel, M.D., Ph.D., as interim CEO. Dr. Mandel will continue as CSO and a director. Mr. DuMoulin...

May 25, 2023

Executive Moves

Conavi Medical names CV device veteran Brian Chambless as CCO

Conavi Medical appointed accomplished cardiovascular medical device industry veteran, Brian Chambless, to the newly created position of chief commercial officer (CCO). In an executive management career spanning more...

May 15, 2023

Executive Moves

PharmaJet names Nathalie Landry as CSO

PharmaJet appointed Nathalie Landry as chief scientific officer to provide strategic leadership and ensure the company’s clinical and scientific programs align with its global commercial expansion. PharmaJet’s pipeline...

May 2, 2023

Executive Moves

Jeffrey Dayno named president, CEO of Harmony Biosciences

Harmony Biosciences (NASDAQ:HRMY) appointed Jeffrey Dayno, M.D., as president and CEO, and a member of the board. Dr. Dayno, a nationally recognized neuroscience expert, joined Harmony as CMO and EVP when the company...

April 24, 2023

Executive Moves

IntelGenx makes organizational changes to support global growth strategy

IntelGenx Technologies (TSX:IGX; OTCQB:IGXT) appointed Dwight Gorham as CEO, effective immediately, succeeding the company’s founder, Horst Zerbe, Ph.D., who has retired as CEO, but will continue as chairman. The CEO...

April 13, 2023

Executive Moves

NervGen appoints Michael Kelly as president, CEO

NervGen Pharma (TSXV:NGEN; OTCQX:NGENF) named Michael Kelly to the position of president and CEO, effective April 10, as well as a member of the board. In a statement, Bill Radvak, executive chairman of NervGen, said Mr...

April 10, 2023

Executive Moves

Hepion expands SAB with appointments of four liver disease KOLs

Hepion Pharmaceuticals (NASDAQ:HEPA) added four new internationally recognized thought leaders to its scientific advisory board (SAB), effective immediately. These new members, who bring decades of liver disease...

March 30, 2023

Executive Moves

OpSens names John Hannigan as CFO

OpSens (TSX:OPS; OTCQX:OPSSF) appointed John Hannigan as CFO, effective immediately. Mr. Hannigan is a highly experienced financial executive with more than 22 years of proven financial expertise with domestic and...

March 27, 2023

Executive Moves

Dylan Dupuis joins ROTH MKM healthcare research team

Dylan Dupuis, Ph.D., has joined ROTH MKM’s healthcare research team as managing director, senior research analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap...

March 13, 2023

Executive Moves

Heron names renowned healthcare investor Kevin Kotler to the board

Heron Therapeutics (NASDAQ:HRTX) appointed three new directors to the board, including Kevin Kotler, a renowned healthcare investor, founder and portfolio manager of Broadfin Capital. Mr. Kotler has over 30 years of...

February 24, 2023

Executive Moves

Elucid names Scott Burger as CCO

Elucid, a closely-held medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, appointed Scott Burger as chief commercial officer. His...

January 26, 2023

Aurinia appoints Hepion’s Dr. Robert T. Foster to board

Enzo Biochem names Kara Cannon as interim CEO

Sernova names Cynthia Pussinen as CEO

Zoe Heineman joins Hygieia as VP of BD

Veteran investment banker Jed Cohen joins Raymond James

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

iBio names Dr. Martin Brenner and Felipe Duran as permanent CEO and CFO, respectively

Marie Mazur appointed chair of PharmaJet board

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

Ondine Biomedical names Simon Sinclair as CMO

Theralase names Roger DuMoulin-White as president and CEO

Conavi Medical names CV device veteran Brian Chambless as CCO

PharmaJet names Nathalie Landry as CSO

Jeffrey Dayno named president, CEO of Harmony Biosciences

IntelGenx makes organizational changes to support global growth strategy

NervGen appoints Michael Kelly as president, CEO

Hepion expands SAB with appointments of four liver disease KOLs

OpSens names John Hannigan as CFO

Dylan Dupuis joins ROTH MKM healthcare research team

Heron names renowned healthcare investor Kevin Kotler to the board

Elucid names Scott Burger as CCO

General

More